Parallel approaches to the discovery of novel BRD4 inhibitors

被引：0

作者：

Jones, David H. ^{[1
]}

de Groot, Marcel J. ^{[1
]}

Heald, Robert ^{[1
]}

Arhin, Ebenezer ^{[1
]}

Goodwin, Ria ^{[1
]}

Burton, Brenda ^{[1
]}

Kulagowski, Jan ^{[1
]}

Brown, David ^{[1
]}

Irving, Steven ^{[1
]}

Bazin, Richard ^{[1
]}

Bruce, Deborah ^{[1
]}

Devos, Rene ^{[1
]}

Price, Steven ^{[1
]}

Ray, Nick ^{[1
]}

Lockey, Peter ^{[1
]}

Montana, John ^{[1
]}

Albertella, Mark R. ^{[1
]}

Green, Simon R. ^{[1
]}

机构：

[1] Argenta, Harlow, Essex, England

来源：

CANCER RESEARCH | 2014年 / 74卷 / 19期

关键词：

D O I：

10.1158/1538-7445.AM2014-5137

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5137

引用

页数：1

共 50 条

[21] An Overview on Small Molecule Inhibitors of BRD4
Huang, Wenhai
Zheng, Xiaoliang
Yang, Yewei
Wang, Xiaoju
Shen, Zhengrong
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (17) : 1403 - 1414
[22] Discovery of the First BRD4 Second Bromodomain (BD2)-Selective Inhibitors
Li, Junhua
Hu, Qingqing
Zhu, Run
Dong, Ruibo
Shen, Hui
Hu, Jiankang
Zhang, Cheng
Zhang, Xiaohan
Xu, Tingting
Xiang, Qiuping
Zhang, Yan
Lin, Bin
Zhao, Linxiang
Wu, Xishan
Xu, Yong
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 21577 - 21616
[23] New inhibitors of BRD4 identified by combining fragment-based and HTS approaches
Borysko, Petro
Vasykhenko, Olexander
Zozulya, Sergey
Moroz, Yurii
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
[24] Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding Simulations
Allen, Bryce K.
Mehta, Saurabh
Ember, Stuart W. J.
Zhu, Jin-Yi
Schonbrunn, Ernst
Ayad, Nagi G.
Schurer, Stephan C.
ACS OMEGA, 2017, 2 (08): : 4760 - 4771
[25] Design, synthesis, and antitumor evaluation of triazolopyridine derivatives as novel inhibitors for BRD4
Liu, Jing-Ying
Zhang, Hong-En
Wang, Cheng
Zhang, Ping-Fan
Xu, Yun-Gen
Shi, Lei
Sun, Li-Ping
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 285
[26] Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors
Noguchi-Yachide, Tomomi
Sakai, Taki
Hashimoto, Yuichi
Yamaguchi, Takao
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (05) : 953 - 959
[27] BRD4 Degradation By Protacs Represents a More Effective Therapeutic Strategy Than BRD4 Inhibitors in DLBCL
Lu, Jing
Qian, Yimin
Raina, Kanak
Altieri, Martha
Dong, Hanqing
Wang, Jing
Chen, Xin
Crew, Andrew
Coleman, Kevin
Crews, Craig
Winkler, James
BLOOD, 2015, 126 (23)
[28] Design, synthesis and biological evaluation of imidazolopyridone derivatives as novel BRD4 inhibitors
Yang, Yifei
Chen, Pan
Zhao, Leilei
Zhang, Bing
Xu, Changliang
Zhang, Huibin
Zhou, Jinpei
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 29
[29] Targeting Brd4 for cancer therapy: inhibitors and degraders
Duan, Yingchao
Guan, Yuanyuan
Qin, Wenping
Zhai, Xiaoyu
Yu, Bin
Liu, Hongmin
MEDCHEMCOMM, 2018, 9 (11) : 1779 - 1802
[30] Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking
Zhao, Hongtao
Gartenmann, Lisa
Dong, Jing
Spiliotopoulos, Dimitrios
Caflisch, Amedeo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (11) : 2493 - 2496

← 1 2 3 4 5 →